Department of Medicine

December 18, 2013

Targeting tumor “supply lines”

A metabolic enzyme plays a crucial role in vascular development and may be a good target for cancer therapies.

By Leigh MacMillan
December 12, 2013

Brady, Rothman set for AACH leadership roles

Donald Brady, M.D., senior associate dean for Graduate Medical Education and Continuing Professional Development, will serve a one-year term as chair of the board of directors of the American Academy on Communication in Healthcare (AACH) for 2014. Brady spent this year serving as president and will transition into a one-year role as chair.

By VUMC News and Communications
December 5, 2013

Day of events highlights efforts to fight diabetes

Vanderbilt University’s contributions to the field of diabetes — past and present — were celebrated recently during the annual Diabetes Day at the Vanderbilt Student Life Center.

By Bill Snyder
November 25, 2013

Vanderbilt celebrates 18 elected fellows of the AAAS

Eighteen academic and administrative leaders at Vanderbilt University have been elected fellows of the American Association for the Advancement of Science (AAAS) this year.

By Bill Snyder
November 14, 2013

Aronoff to lead Division of Infectious Diseases

David Aronoff, M.D., has been named the new director of Vanderbilt University Medical Center’s Division of Infectious Diseases.

By Jessica Pasley
November 7, 2013

Neurotransmitter’s role in bone balance

Removal of the neurotransmitter norepinephrine from the space outside cells plays an important role in the regulation of bone remodeling.

By Leigh MacMillan
October 30, 2013

Preserving antibiotic arsenal for TB

Clinicians should be cautious about prescribing newer fluoroquinolone antibiotics to patients with TB risk factors; doing so may jeopardize the use of these agents against TB.
By Leigh MacMillan
October 24, 2013

Study sheds new light on type 2 diabetes development

Inactivation by oxidative stress of specific transcription factors essential for pancreatic islet beta cell function is a key event in the development of type 2 diabetes, Vanderbilt University researchers and their colleagues have found.
By Bill Snyder
October 14, 2013

Magnesium impacts vitamin D status

Magnesium and vitamin D appear to work together to reduce risk of death from cardiovascular disease and colorectal cancer.
By VUMC News and Communications
October 10, 2013

Talbot lands epidemiology award

Thomas Talbot, M.D., MPH, associate professor of Medicine and Chief Hospital Epidemiologist at Vanderbilt University Medical Center, received the 2013 Investigator Award from the Society for Healthcare Epidemiology of America (SHEA) at the organization’s Annual Scientific Meeting last week in San Francisco.
By VUMC News and Communications
October 10, 2013

Probing mutant EGF receptor regulation

Understanding the regulation of mutant EGF receptors commonly found in lung cancers could lead to new targeted therapies.
By Leigh MacMillan
October 3, 2013

Study finds cognitive deficits common after critical illness

Patients treated in intensive care units across the globe enter their medical care with no evidence of cognitive impairment but often leave with deficits similar to those seen in patients with traumatic brain injury (TBI) or mild Alzheimer’s disease (AD) that persist for at least a year, according to a Vanderbilt University Medical Center study published today in the New England Journal of Medicine.
By Craig Boerner
October 3, 2013

Framingham Heart Study’s landmark impact examined

While the Framingham Heart Study is often referenced throughout the halls of academia, few know its origin or can fully appreciate the contribution it has made to the understanding and prevention of cardiovascular disease.
By Kathy Whitney
1 … 105 106 107 108 109 … 123